Article
Decades-long elevation of interferon-α drives a Sjögren disease endotype: an interdisciplinary study
2025-08-07
Abstract excerpt
<h4>SUMMARY</h4> <h4>BACKGROUND</h4> Mechanistic heterogeneity is a major obstacle to the development of effective treatment for Sjögren disease (SjD) and there is a pressing need to stratify SjD according to precision medicine principles. Aberrant activation of the type I interferon (IFN) pathway represents a leading candidate pathway, but a causal role of elevated IFN-α in driving a Sjögren disease endotype re...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c5c94df6-063c-51ed-802b-14648638c87c
- DOI
- 10.1101/2025.08.06.668845
